SAT-213 Relationship of Cardiovascular disease with dialysis dosage

作者：Muhammad Abbas, Sidra Saleem, Z. Rasool, Arshad Sheikh, Ninad Zaman, Md Shahid Sarwar, Antônio de Pádua Mansur · 发表于：Kidney International Reports · 年份：2020 · DOI：10.1016/j.ekir.2020.02.228 · 研究领域：Dialysis and Renal Disease Management、Erythropoietin and Anemia Treatment

Cardiovascular Disease (CVD) is the leading cause of death in End Stage Renal Disease (ESRD) patients on Maintenance Hemodialysis (MHD). The accumulation of uremic toxins play a part in the pathophysiology of cardiovascular disease that may progress to myocardial fibrosis, cardiomyopathy, left ventricular hypertrophy, vascular calcification and atherosclerosis. Thus, morbidity and mortality in hemodialysis patients is closely correlated to the delivered dialysis dose. The delivered dose is measured in MHD patients either by blood samples to calculate single pool Kt/V or by measuring the ionic dialysance in real time using online clearance monitoring (OCM).